O'Dowd Sarah A has filed 6 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 2695 shares of Protagonist Therapeutics, Inc ($PTGX) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Protagonist Therapeutics, Inc | $PTGX | O'Dowd Sarah A | Director | A | Common Stock | 2695 | $0.00 | 7,825.0000 | 63,573,048 | 52.53% | 0.00% |
| Jan. 2, 2026 | Protagonist Therapeutics, Inc | $PTGX | O'Dowd Sarah A | Director | A | Stock Option (right to buy) | 3762 | $0.00 | 3,762.0000 | 63,573,048 | 9999.99% | 0.01% |
| Jan. 2, 2025 | Protagonist Therapeutics, Inc | $PTGX | O'Dowd Sarah A | Director | A | Common Stock | 5130 | $0.00 | 5,130.0000 | 65,077,722 | 9999.99% | 0.01% |
| Jan. 2, 2025 | Protagonist Therapeutics, Inc | $PTGX | O'Dowd Sarah A | Director | A | Stock Option (right to buy) | 6584 | $0.00 | 6,584.0000 | 65,077,722 | 9999.99% | 0.01% |
| May 15, 2024 | ICHOR HOLDINGS, LTD. | $ICHR | O'Dowd Sarah A | Director | A | Ordinary Shares, par value $0.0001 | 3923 | $0.00 | 28,325.0000 | 0 | 16.08% | 0.00% |
| Jan. 2, 2024 | Protagonist Therapeutics, Inc | $PTGX | O'Dowd Sarah A | Director | A | Stock Option (right to buy) | 25700 | $0.00 | 25,700.0000 | 56,763,559 | 9999.99% | 0.05% |